The Procter & Gamble Company (NYSE:PG) Shares Purchased by O Brien Greene & Co. Inc

O Brien Greene & Co. Inc grew its position in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 8.7% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,179 shares of the company’s stock after buying an additional 254 shares during the quarter. O Brien Greene & Co. Inc’s holdings in Procter & Gamble were worth $524,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also made changes to their positions in PG. HighPoint Advisor Group LLC purchased a new stake in Procter & Gamble in the 4th quarter valued at approximately $17,696,000. Bayesian Capital Management LP boosted its stake in shares of Procter & Gamble by 43.0% in the fourth quarter. Bayesian Capital Management LP now owns 52,840 shares of the company’s stock valued at $7,743,000 after buying an additional 15,900 shares in the last quarter. Steele Capital Management Inc. acquired a new position in Procter & Gamble during the first quarter worth $204,000. Gilbert & Cook Inc. grew its holdings in Procter & Gamble by 7.7% during the fourth quarter. Gilbert & Cook Inc. now owns 17,215 shares of the company’s stock worth $2,523,000 after acquiring an additional 1,237 shares during the period. Finally, Mosley Wealth Management purchased a new position in Procter & Gamble in the fourth quarter worth $537,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Down 0.7 %

PG opened at $175.93 on Wednesday. The stock has a market capitalization of $415.22 billion, a price-to-earnings ratio of 28.75, a price-to-earnings-growth ratio of 3.76 and a beta of 0.41. The Procter & Gamble Company has a 12 month low of $141.45 and a 12 month high of $177.94. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.73 and a quick ratio of 0.53. The business has a 50-day moving average of $169.80 and a two-hundred day moving average of $165.49.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings results on Tuesday, July 30th. The company reported $1.40 EPS for the quarter, topping the consensus estimate of $1.37 by $0.03. The firm had revenue of $20.53 billion during the quarter, compared to analyst estimates of $20.69 billion. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. Procter & Gamble’s revenue for the quarter was down .1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.37 earnings per share. On average, research analysts expect that The Procter & Gamble Company will post 6.97 earnings per share for the current year.

Procter & Gamble Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Friday, July 19th were paid a $1.0065 dividend. This represents a $4.03 annualized dividend and a dividend yield of 2.29%. The ex-dividend date of this dividend was Friday, July 19th. Procter & Gamble’s dividend payout ratio is currently 65.85%.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on PG. Barclays cut their price target on shares of Procter & Gamble from $174.00 to $163.00 and set an “overweight” rating for the company in a report on Thursday, August 1st. StockNews.com downgraded Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. DZ Bank raised Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price target for the company in a research note on Thursday, August 29th. JPMorgan Chase & Co. dropped their target price on shares of Procter & Gamble from $181.00 to $179.00 and set an “overweight” rating for the company in a report on Wednesday, July 31st. Finally, TD Cowen assumed coverage on shares of Procter & Gamble in a report on Tuesday, July 23rd. They issued a “buy” rating and a $189.00 price target on the stock. Seven investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $175.79.

Read Our Latest Research Report on Procter & Gamble

Insider Transactions at Procter & Gamble

In other news, insider Balaji Purushothaman sold 8,842 shares of the stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the sale, the insider now owns 11,537 shares of the company’s stock, valued at $1,902,451.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other Procter & Gamble news, insider Susan Street Whaley sold 450 shares of the stock in a transaction that occurred on Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total transaction of $76,149.00. Following the transaction, the insider now owns 13,072 shares of the company’s stock, valued at approximately $2,212,043.84. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Balaji Purushothaman sold 8,842 shares of the firm’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the transaction, the insider now owns 11,537 shares in the company, valued at $1,902,451.30. The disclosure for this sale can be found here. In the last quarter, insiders sold 375,553 shares of company stock worth $63,829,141. 0.17% of the stock is currently owned by company insiders.

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.